Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.45 |
| ▸ | MPL | P40238 | 6/20 | 0.44 |
| ▸ | CTRC | Q99895 | 2/20 | 0.44 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.43 |
| ▸ | EP300 | Q09472 | 1/20 | 0.43 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.43 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.43 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13994930 | 0.86 | MPL (0.50) | CYP1A2CYP2C9MAPK1DNASE1L3MPL | |
| SCHEMBL13238842 | 0.86 | MPL (0.50) | CYP1A2CYP2C9MAPK1DNASE1L3MPL | |
| SCHEMBL14542974 | 0.85 | CYP1A2 (0.47) | CYP1A2CYP2C9MAPK1DNASE1L3MPL | |
| SCHEMBL9275771 | 0.80 | CYP1A2 (0.43) | CYP1A2CYP2C9MAPK1DNASE1L3MPL | |
| SCHEMBL9275764 | 0.80 | CYP1A2 (0.43) | CYP1A2CYP2C9MAPK1DNASE1L3MPL | |
| SCHEMBL13852025 | 0.78 | MPL (0.50) | CYP1A2CYP2C9MAPK1DNASE1L3MPL | |
| SCHEMBL13994851 | 0.78 | MPL (0.50) | CYP1A2CYP2C9MAPK1DNASE1L3MPL | |
| SCHEMBL23787644 | 0.77 | CYP1A2 (0.47) | CYP1A2CYP2C9MAPK1DNASE1L3MPL | |
| SCHEMBL13599456 | 0.77 | PHLPP2 (0.43) | CYP1A2CYP2C9MAPK1DNASE1L3MPL | |
| SCHEMBL12943030 | 0.77 | PRMT3 (0.61) | CYP1A2CYP2C9MAPK1DNASE1L3MPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8167991-B2 | Trisazo compound, ink composition, recording method, and colored article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20090062545-A1 | Trisazo Compound, Ink Composition, Recording Method, and Colored Article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062545-A1 | Trisazo Compound, Ink Composition, Recording Method, and Colored Article | JAK1, TMT1A, CDK1 | CYP1A2 1285/4885CYP2C9 1360/4885MAPK1 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.